Inventor
Laurent Poirot
Inventor
Paris, FR
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes26%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides20%
C12YEnzymes7%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
11,072,644Inhibitory chimeric antigen receptors202110,988,542Chimeric antigen receptors with integrated controllable functions202110,894,093Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation202110,870,864Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system202010,836,998Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells202010,765,728Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment202010,584,352Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system202010,517,896Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells201910,472,613Method for modulating car-induced immune cells activity201910,426,795Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells201910,363,270Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy201910,286,007Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells201910,239,948Method of engineering multi-input signal sensitive T cell for immunotherapy201910,196,608Method for in situ inhibition of regulatory T cells20199,890,393'Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system'20189,855,297'Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system'2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to CELLECTIS (16)· patent assignee history
2018–2021Based in Paris, FR· patent location history
2021Patents assigned to ALLOGENE THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELLECTIS | 16 | 2018–2021 |
| ALLOGENE THERAPEUTICS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Paris, FR | 16 | 2018–2021 |